Navigation Links
Corgenix Reports Third Quarter Fiscal 2008 Financial Results
Date:5/15/2008

Total revenues for the quarter decrease approximately 3% vs. prior year

DENVER, May 15 /PRNewswire-FirstCall/ -- Corgenix Medical Corporation (OTC Bulletin Board: CONX), a worldwide developer and marketer of diagnostic test kits, today filed its third quarter Form 10-QSB and reported financial results. The report disclosed that the company's sales and operating results have advanced during the quarter and nine months ended March 31, 2008, and further confirmed that the initiatives the company put in place several months earlier are continuing to prove effective. Some of the results highlighted by the report are as follows:

-- Total revenues for the quarter decreased $61,166 or 3.1% vs. the prior

year's comparable quarter.

-- Revenues, excluding contract manufacturing, increased $186,686 or 10.6%

vs. the prior year's comparable quarter.

-- Total operating expenses decreased $30,009 or 2.4% vs. the prior year's

comparable quarter.

-- Operating loss for the quarter was $62,912 vs. an operating loss of

$37,423 in the prior year's comparable quarter.

-- Net loss for the quarter was $352,102 vs. $329,370 in the prior year's

comparable quarter.

"While much was accomplished in the quarter, including product sales growth and reduction in operating expenses, the overall financial results in the third quarter were less than we had expected, reflecting to some extent, the timing of our sales orders, but to a greater extent, softer sales in the contract manufacturing aspect of our business, which was a direct result of the new business strategy of our largest contract manufacturing customer," said Douglass Simpson, President and CEO of Corgenix. "Excluding contract manufacturing, our sales increased 10.6% over the same period in the prior year. It's important to recognize that Corgenix is still growing well ahead of industry averages -- our sales are up almost 20% for the nine m
'/>"/>

SOURCE Corgenix Medical Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Corgenix to Exhibit AspirinWorks(R) Test at 2008 ACOFP Meeting in Denver
2. Tiens Biotech Group (USA) Reports First Quarter Results
3. Cardiogenesis Reports First Quarter 2008 Results
4. STEN Corp. Reports 2008 Second-Quarter Revenue of $4.3 Million and Improved Results From Operations
5. Alseres Pharmaceuticals, Inc. Reports First Quarter 2008 Operational and Financial Results
6. The Female Health Company Reports 267% Increase in Second Quarter Earnings
7. NicOx Reports First Quarter 2008 Financial Results
8. Hill-Rom Reports Second Quarter Revenue Growth of 12.0 Percent to $375.2 Million and Adjusted Earnings Per Fully Diluted Share from Continuing Operations of $0.26, Unchanged from the Prior Year
9. IRIDEX Reports First Quarter 2008 Financial Results
10. Cardiome Reports First Quarter Results
11. MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... (PRWEB) July 30, 2014 “North America ... market data on the North America Contrast Media Injectors ... dollars, and volume (in units) and average price data ...     CT Injectors ,     Interventional Cardiology/Angio Injectors and MRI ... contrast agent) is a substance used to enhance the ...
(Date:7/30/2014)... Rochelle, NY, July 30, 2014We have pills to ease pain, ... chronic conditions, and to enhance our sexual and athletic prowess. ... society and could we benefit from taking fewer pills? This ... Pill,: The Role and Fantasy of Pills in Modern Medicine ... Medicine , a peer-reviewed publication from Mary Ann Liebert, Inc., ...
(Date:7/30/2014)... 2014 (HealthDay News) -- Clues to whether a person is ... test, a new study suggests. Chemical changes to a ... help spur suicidal thoughts and behaviors, the study,s authors explained. ... doctors to a patient,s risk for suicide, they said. ... have been stymied in our prevention efforts because we have ...
(Date:7/30/2014)... Angeles, CA (July 30, 2014) With the advent ... become a popular science and researchers must work ... the study of stroke rehabilitation. A new study ... a systematic shift in perspective and suggests that ... would strongly promote stroke motor recovery, for example ...
(Date:7/30/2014)... MEETING, PA (PRWEB) July 30, 2014 ... assistance company and a subsidiary of West Corporation, has ... | MOBILE for its Health Cost Estimator mobile app. ... developed to provide Health Advocate members with the information ... services. , “We are honored that the HCE mobile ...
Breaking Medicine News(10 mins):Health News:Contrast Media Injectors Market in North America (US, Canada, Mexico) to 2020 Report Available at MarketOptimizer.org 2Health News:Contrast Media Injectors Market in North America (US, Canada, Mexico) to 2020 Report Available at MarketOptimizer.org 3Health News:Contrast Media Injectors Market in North America (US, Canada, Mexico) to 2020 Report Available at MarketOptimizer.org 4Health News:Could a Blood Test Predict Suicide Risk? 2Health News:Could a Blood Test Predict Suicide Risk? 3Health News:Neuro researchers advocate for a shift in thinking for stroke rehabilitation 2Health News:Health Advocate™, Inc., Recognized by 16th Annual Web Health Awards for Pricing Transparency Tool 2
... 6 MyFoodMyHealth, Inc. today announced the,launch of ... that provides healthy meal plans, flavorful recipes and ... have multiple health,conditions or allergies. One of ... needs is coming up with one meal everyone ...
... declining economy derail your weight loss goalsENGLEWOOD CLIFFS, N.J., ... spiral, many Americans are alleviating stress by turning to ... high-calorie, less healthy food choices that can lead to ... knowing how to eat right and economically during stressful ...
... Want me to Declaw What?" is a new animal book that takes a ... an out-of-control chimpanzee and a goose named Gary Dr. Matt Toia has seen ... short stories. , ... (PRWEB) January 6, 2009 -- In his new animal book ...
... Jan. 6 The 2008 Frost & Sullivan ... SonoScape Co. Ltd. With a strong focus on developing ... prices, the company has been able to attract significant ... both public and private settings. Backed by its pioneering ...
... OF PRUSSIA, Pa., Jan. 5 Prism ... Drug Administration (FDA) has approved,the new drug ... a,novel, patent-protected, cosolvent free formulation of the ... US by Wyeth as Cordarone(R),Intravenous. NEXTERONE ...
... and what,s hype in infomercial fitness machines; plus tests ... Best BuysYONKERS, N.Y., Jan. 5 Two new reports ... the chaff in home workout equipment -- from ... TV and Internet infomercials, to treadmills, elliptical exercisers, stationary ...
Cached Medicine News:Health News:New Website, MyFoodMyHealth, Helps People Manage Multiple Health Conditions Using Delicious Food 2Health News:New Website, MyFoodMyHealth, Helps People Manage Multiple Health Conditions Using Delicious Food 3Health News:Slim-Fast: An Effective Option to Help Cost-Conscious Americans Manage Their Weight 2Health News:Slim-Fast: An Effective Option to Help Cost-Conscious Americans Manage Their Weight 3Health News:Slim-Fast: An Effective Option to Help Cost-Conscious Americans Manage Their Weight 4Health News:New Animal Book on Veterinary Medicine Features Patients That Don't Play by the Rules 2Health News:Frost & Sullivan Lauds SonoScape's Outstanding Entrepreneurship 2Health News:Frost & Sullivan Lauds SonoScape's Outstanding Entrepreneurship 3Health News:Frost & Sullivan Lauds SonoScape's Outstanding Entrepreneurship 4Health News:Frost & Sullivan Lauds SonoScape's Outstanding Entrepreneurship 5Health News:Prism Pharmaceuticals Receives FDA Approval of NEXTERONE(R) for Life-Threatening Ventricular Fibrillation and Ventricular Tachycardia 2Health News:Prism Pharmaceuticals Receives FDA Approval of NEXTERONE(R) for Life-Threatening Ventricular Fibrillation and Ventricular Tachycardia 3Health News:Prism Pharmaceuticals Receives FDA Approval of NEXTERONE(R) for Life-Threatening Ventricular Fibrillation and Ventricular Tachycardia 4Health News:Prism Pharmaceuticals Receives FDA Approval of NEXTERONE(R) for Life-Threatening Ventricular Fibrillation and Ventricular Tachycardia 5Health News:Consumer Reports: Big Promises of Some Infomercial Exercise Machines Fall Flat; Plus, Set Up a Home Gym for Under $100 2Health News:Consumer Reports: Big Promises of Some Infomercial Exercise Machines Fall Flat; Plus, Set Up a Home Gym for Under $100 3Health News:Consumer Reports: Big Promises of Some Infomercial Exercise Machines Fall Flat; Plus, Set Up a Home Gym for Under $100 4Health News:Consumer Reports: Big Promises of Some Infomercial Exercise Machines Fall Flat; Plus, Set Up a Home Gym for Under $100 5
(Date:7/30/2014)... 2014 /PRNewswire-iReach/ -- Transluminal Technologies LLC, a ... has announced today that they have received CE ... Device. Velox CD™ provides a safe and predictable ... procedures. The single size velox CD™ is indicated ... 5F to 8F.  Velox CD™ utilizes ...
(Date:7/30/2014)...  Decision Resources Group finds that ... imaging system market will be significantly driven by ... computed tomography and magnetic resonance imaging with nuclear ... the need for higher-quality imaging to satisfy more ... spur preclinical imaging system sales. Other ...
(Date:7/30/2014)... KISSING, Germany , July 30, 2014 ... single use and computer-assisted ("robotic") colonoscopy system, today announced ... worldwide recognized medical device executive, as a new member ... is a highly respected global visionary in the medical ... as President and Chief Executive Officer at Given Imaging ...
Breaking Medicine Technology:Transluminal Technologies receives CE Mark approval for velox CD(TM) vascular closure device 2Growing Popularity of Multimodality Imaging Will Drive the Preclinical Animal Research Imaging System Market 2invendo medical Appoints Nachum (Homi) Shamir To The Company's Board Of Directors 2invendo medical Appoints Nachum (Homi) Shamir To The Company's Board Of Directors 3
Freer elevator, double end, 7 1/4", S/B....
... Surgifoam* absorbable gelatin sponge, U.S.P. is ... absorbable sponge intended for hemostatic use ... The sponge is off-white and porous ... to hemostasis, highly favorable surgeon preference ...
8 mm diameter curved probes with suture eyes just back of blunt ends. Stainless steel. Round knurled handle with polished finish. Overall length: 5.6 inches....
Yag Laser System SYL is compact and light-weight. It is CE Mark approved according to MDD....
Medicine Products: